American Century Companies Inc. Has $2.41 Million Position in Clover Health Investments, Corp. (NASDAQ:CLOV)

American Century Companies Inc. increased its position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) by 181.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 764,694 shares of the company's stock after acquiring an additional 492,527 shares during the period. American Century Companies Inc. owned approximately 0.15% of Clover Health Investments worth $2,409,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Steph & Co. grew its stake in shares of Clover Health Investments by 33.3% in the 4th quarter. Steph & Co. now owns 20,000 shares of the company's stock worth $63,000 after purchasing an additional 5,000 shares during the last quarter. Arizona State Retirement System grew its position in Clover Health Investments by 6.3% in the fourth quarter. Arizona State Retirement System now owns 118,265 shares of the company's stock worth $373,000 after buying an additional 6,990 shares during the last quarter. SignalPoint Asset Management LLC increased its holdings in shares of Clover Health Investments by 6.2% in the fourth quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company's stock valued at $504,000 after buying an additional 9,390 shares in the last quarter. Silverleafe Capital Partners LLC lifted its position in shares of Clover Health Investments by 182.9% during the 4th quarter. Silverleafe Capital Partners LLC now owns 45,000 shares of the company's stock valued at $142,000 after acquiring an additional 29,091 shares during the last quarter. Finally, HighTower Advisors LLC bought a new stake in shares of Clover Health Investments during the 3rd quarter worth $97,000. 19.77% of the stock is currently owned by institutional investors.

Clover Health Investments Price Performance

Clover Health Investments stock traded up $0.01 during trading hours on Friday, hitting $3.68. The company had a trading volume of 5,039,863 shares, compared to its average volume of 6,838,878. The firm's fifty day moving average is $3.89 and its 200-day moving average is $3.74. The firm has a market capitalization of $1.88 billion, a P/E ratio of -18.40 and a beta of 1.98. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.87.

Insider Transactions at Clover Health Investments

In other news, Director Carladenise Armbrister Edwards sold 200,000 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $3.61, for a total value of $722,000.00. Following the completion of the sale, the director now directly owns 273,227 shares of the company's stock, valued at approximately $986,349.47. This represents a 42.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brady Patrick Priest sold 75,000 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.68, for a total transaction of $276,000.00. Following the completion of the sale, the chief executive officer now owns 2,418,151 shares in the company, valued at $8,898,795.68. This represents a 3.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 327,500 shares of company stock valued at $1,197,500. 22.28% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CLOV shares. Craig Hallum assumed coverage on Clover Health Investments in a report on Tuesday, December 17th. They set a "buy" rating and a $6.00 target price for the company. Canaccord Genuity Group raised their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a report on Monday, March 3rd.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.